MEQU is participating in the THOR RDCR Symposium in Bergen, Norway, on June 27th – 29th.

The RDCR Symposium brings together investigators who are interested in analyzing the efficacy and safety of Full Whole Blood (FWH) for patients with severe traumatic hemorrhagic shock.

The Trauma Hemostasis and Oxygenation Research (THOR) Network is an international multidisciplinary group of investigators that aims to improve outcomes and safety in patients with severe traumatic injury through improved monitoring and resuscitation techniques. The research the Network performs includes both pre-hospital and hospital phases of care with attention to both military and civilian applications.

To learn more about THOR click here